OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
July 08, 2021
LGM Pharma will offer contract analytical testing and stability services to pharmaceutical developers and manufacturers.
July 02, 2021
CMOs and CDMOs adjust business processes as demand for COVID-19 treatments and non-pandemic related therapies puts pressure on the bio/pharma industry.
July 01, 2021
The extended manufacturing agreement between Pinteon and Lonza enables future clinical production of PNT001, a novel Tau antibody therapeutic that targets Alzheimer's disease and traumatic brain injury.
Selexis and KBI Biopharma will use integrated services to advance Immatics’ TCR bispecifics drug development program to the IND stage.
WuXi STA’s Delaware campus will contain clinical and commercial manufacturing capabilities for small molecules and novel molecular modalities.
Developing bioassay methods requires a new approach for cell and gene therapy drug development.
June 30, 2021
CDMO Yposkesi will increase its current gene therapy vector capacity through French government’s “Plan de Relance” scheme.
June 24, 2021
The companies will utilize the Cocoon Platform for clinical point-of-care manufacturing.
The companies have entered into an agreement to develop processes for a novel immunotherapy protein.
June 23, 2021
Centrient started production at its new statins API manufacturing unit in Toansa, India.